12553
A 27-year - old man who had a history of bronchial asthma , eosinophilic enteritis , and eosinophilic pneumonia presented with fever , skin eruptions , cervical lymphadenopathy , hepatosplenomegaly , atypical lymphocytosis , and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment .
 adverse effect: atypical lymphocytosis, SMX; adverse effect: atypical lymphocytosis, sulfamethoxazole; adverse effect: atypical lymphocytosis, TMP; adverse effect: atypical lymphocytosis, trimethoprim; adverse effect: cervical lymphadenopathy, SMX; adverse effect: cervical lymphadenopathy, sulfamethoxazole; adverse effect: cervical lymphadenopathy, TMP; adverse effect: cervical lymphadenopathy, trimethoprim; adverse effect: eosinophilia, SMX; adverse effect: eosinophilia, sulfamethoxazole; adverse effect: eosinophilia, TMP; adverse effect: eosinophilia, trimethoprim; adverse effect: fever, SMX; adverse effect: fever, sulfamethoxazole; adverse effect: fever, TMP; adverse effect: fever, trimethoprim; adverse effect: hepatosplenomegaly, SMX; adverse effect: hepatosplenomegaly, sulfamethoxazole; adverse effect: hepatosplenomegaly, TMP; adverse effect: hepatosplenomegaly, trimethoprim; adverse effect: skin eruptions, SMX; adverse effect: skin eruptions, sulfamethoxazole; adverse effect: skin eruptions, TMP; adverse effect: skin eruptions, trimethoprim
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  atypical lymphocytosis, SMX; atypical lymphocytosis, sulfamethoxazole; atypical lymphocytosis, TMP; atypical lymphocytosis, trimethoprim; cervical lymphadenopathy, SMX; cervical lymphadenopathy, sulfamethoxazole; cervical lymphadenopathy, TMP; cervical lymphadenopathy, trimethoprim; eosinophilia, SMX; eosinophilia, sulfamethoxazole; eosinophilia, TMP; eosinophilia, trimethoprim; fever, SMX; fever, sulfamethoxazole; fever, TMP; fever, trimethoprim; hepatosplenomegaly, SMX; hepatosplenomegaly, sulfamethoxazole; hepatosplenomegaly, TMP; hepatosplenomegaly, trimethoprim; skin eruptions, SMX; skin eruptions, sulfamethoxazole; skin eruptions, TMP; skin eruptions, trimethoprim 
Answer:
 adverse effect: atypical lymphocytosis, SMX; adverse effect: atypical lymphocytosis, sulfamethoxazole; adverse effect: atypical lymphocytosis, TMP; adverse effect: atypical lymphocytosis, trimethoprim; adverse effect: cervical lymphadenopathy, SMX; adverse effect: cervical lymphadenopathy, sulfamethoxazole; adverse effect: cervical lymphadenopathy, TMP; adverse effect: cervical lymphadenopathy, trimethoprim; adverse effect: eosinophilia, SMX; adverse effect: eosinophilia, sulfamethoxazole; adverse effect: eosinophilia, TMP; adverse effect: eosinophilia, trimethoprim; adverse effect: fever, SMX; adverse effect: fever, sulfamethoxazole; adverse effect: fever, TMP; adverse effect: fever, trimethoprim; adverse effect: hepatosplenomegaly, SMX; adverse effect: hepatosplenomegaly, sulfamethoxazole; adverse effect: hepatosplenomegaly, TMP; adverse effect: hepatosplenomegaly, trimethoprim; adverse effect: skin eruptions, SMX; adverse effect: skin eruptions, sulfamethoxazole; adverse effect: skin eruptions, TMP; adverse effect: skin eruptions, trimethoprim